Hamilton Health Sciences Corporation   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Hamilton Canada (1996)

Organization Overview

First Clinical Trial
1997
NCT00182169
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Gail Gauvreau | Hamilton Health Sciences Corporation | Hamilton Health Sciences Foundation - New Investigator Fund | Hamilton Health Sciences - Juravinski Hospital | Juravinski Cancer Centre at Hamilton Health Sciences Centre, ON Canada | Juravinski Cancer Centre at Hamilton Health Sciences, Ontario Canada | Michael G. DeGroote Pain Clinic, Hamilton Health Sciences